Department of Pharmacy, Unit of Pharmacology and Toxicology, University of Genoa, 16148, Genoa, Italy.
Department of Pharmacy, Laboratory of Biochemistry, University of Genoa, 16132, Genoa, Italy.
Mol Neurobiol. 2018 Dec;55(12):9220-9233. doi: 10.1007/s12035-018-1059-z. Epub 2018 Apr 14.
Amyotrophic lateral sclerosis (ALS) is an adult-onset fatal neurodegenerative disease characterized by muscle wasting, weakness, and spasticity due to a progressive degeneration of cortical, brainstem, and spinal motor neurons. The etiopathological causes are still largely obscure, although astrocytes definitely play a role in neuronal damage. Several mechanisms have been proposed to concur to neurodegeneration in ALS, including mitochondrial dysfunction. We have previously shown profound modifications of glutamate release and presynaptic plasticity in the spinal cord of the SOD1 mouse model of ALS. In this work, we characterized, for the first time, the aerobic metabolism in two specific compartments actively involved in neurotransmission (i.e. the presynaptic district, using purified synaptosomes, and the perisynaptic astrocyte processes, using purified gliosomes) in SOD1 mice at different stages of the disease. ATP/AMP ratio was lower in synaptosomes isolated from the spinal cord, but not from other brain areas, of SOD1 vs. control mice. The energy impairment was linked to altered oxidative phosphorylation (OxPhos) and increment of lipid peroxidation. These metabolic dysfunctions were present during disease progression, starting at the very pre-symptomatic stages, and did not depend on a different number of mitochondria or a different expression of OxPhos proteins. Conversely, gliosomes showed a reduction of the ATP/AMP ratio only at the late stages of the disease and an increment of oxidative stress also in the absence of a significant decrement in OxPhos activity. Data suggest that the presynaptic neuronal moiety plays a pivotal role for synaptic energy metabolism dysfunctions in ALS. Changes in the perisynaptic compartment seem subordinated to neuronal damage.
肌萎缩侧索硬化症(ALS)是一种成人发病的致命神经退行性疾病,其特征是由于皮质、脑干和脊髓运动神经元的进行性退化导致肌肉萎缩、无力和痉挛。虽然星形胶质细胞在神经元损伤中肯定起作用,但病因仍很大程度上不清楚。已经提出了几种机制来共同导致 ALS 中的神经退行性变,包括线粒体功能障碍。我们之前已经在 ALS 的 SOD1 小鼠模型的脊髓中显示了谷氨酸释放和突触前可塑性的深刻改变。在这项工作中,我们首次描述了在疾病的不同阶段,两种特定的参与神经传递的活跃部位(即使用纯化的突触小体的突触前区和使用纯化的神经胶质小体的近突触星形胶质细胞过程)中的有氧代谢。与对照小鼠相比,SOD1 小鼠脊髓分离的突触小体中 ATP/AMP 比值较低,但其他脑区则没有。能量损伤与氧化磷酸化(OxPhos)改变和脂质过氧化增加有关。这些代谢功能障碍在疾病进展过程中存在,从非常早期的症状前阶段开始,并且不依赖于不同数量的线粒体或 OxPhos 蛋白的不同表达。相反,神经胶质小体仅在疾病的晚期显示 ATP/AMP 比值降低,并且在 OxPhos 活性没有明显降低的情况下也显示氧化应激增加。数据表明,突触前神经元部分在 ALS 中的突触能量代谢功能障碍中起关键作用。近突触区的变化似乎次于神经元损伤。